Cowboys COVID-19 news: Which Cowboys players are on the COVID-19 Week 17 roster?

0

The Dallas Cowboys clinched the NFC East title and will spend the final two weeks of the regular season trying to clinch the No.1 seed and the NFC home ground. They are one game behind the Packers but hold the tiebreaker advantage with a better conference record.

The Cowboys have been able to avert significant COVID-19 issues this season. They’ve had positive cases, but they haven’t had the kind of outbreak that has decimated teams like the Ravens and Saints. Below is the list of players on their reserve / COVID-19 roster. We’ll update this list as things change over the past couple of weeks.

List of COVID-19 Cowboys

WR Simi Fehko (placed on Friday, December 24)
DT Trysten Hill (placed on Saturday December 18th)
DT Osa Odighizuwa (placed on Saturday December 18)
LB Francis Bernard (placed Mon 27 Dec)
CB Jourdan Lewis (placed on Friday, December 24)
S Malik Hooker (placed Thu 23 December)

NFL COVID-19 Protocols

If not vaccinated, a player must miss five days if it is close contact and ten days if it is a positive test. If vaccinated, a player does not have to miss a game as a close contact. If he tests positive, he can come back if he has been asymptomatic for at least 24 hours by one of the following options:

  1. He receives two BRL PCR test results that are either negative or that produce cycle cutoff (CT) values ​​of 35 or greater; WHERE
  2. He receives a negative BRL PCR test result or one producing CT values ​​of 35 or greater and a negative Mesa test result from a test performed within 24 hours of the BRL PCR test. The two tests can be performed at the same time or within 24 hours of each other; WHERE
  3. It receives two negative MESA tests 24 hours after the initial collection, but can be taken simultaneously as long as they are two new separate collections.

The previous policy required two negative tests at least 24 hours apart, but this has been significantly reduced with these new protocols.


Source link

Share.

Comments are closed.